News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
693,345 Results
Type
Article (56493)
Company Profile (172)
Press Release (636664)
Multimedia
Podcasts (168)
Webinars (27)
Section
Business (185462)
Career Advice (2577)
Deals (33678)
Drug Delivery (155)
Drug Development (79436)
Employer Resources (167)
FDA (17697)
Job Trends (14651)
News (326394)
Policy (34785)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2757)
Academic (1)
Accelerated approval (45)
Adcomms (37)
Allergies (167)
Alliances (46946)
ALS (198)
Alzheimer's disease (1842)
Antibody-drug conjugate (ADC) (401)
Approvals (17929)
Artificial intelligence (652)
Autoimmune disease (237)
Automation (46)
Bankruptcy (345)
Best Places to Work (11036)
BIOSECURE Act (23)
Biosimilars (214)
Biotechnology (107)
Bladder cancer (186)
Brain cancer (68)
Breast cancer (691)
Cancer (5446)
Cardiovascular disease (489)
Career advice (2183)
Career pathing (44)
CAR-T (310)
CDC (71)
Celiac Disease (2)
Cell therapy (842)
Cervical cancer (43)
Clinical research (68587)
Collaboration (1926)
Company closure (6)
Compensation (1283)
Complete response letters (90)
COVID-19 (2898)
CRISPR (101)
C-suite (996)
Cystic fibrosis (157)
Data (7047)
Decentralized trials (3)
Denatured (48)
Depression (173)
Dermatology (59)
Diabetes (570)
Diagnostics (6612)
Digital health (52)
Diversity (10)
Diversity, equity & inclusion (43)
Drug discovery (304)
Drug pricing (233)
Drug shortages (35)
Duchenne muscular dystrophy (281)
Earnings (76155)
Editorial (71)
Employer branding (20)
Employer resources (149)
Events (104607)
Executive appointments (1053)
FDA (21222)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (28)
Funding (1597)
Gene editing (220)
Generative AI (59)
Gene therapy (708)
GLP-1 (1170)
Government (4912)
Grass and pollen (8)
Guidances (397)
Healthcare (18871)
HIV (76)
Huntington's disease (56)
IgA nephropathy (96)
Immunology and inflammation (323)
Immuno-oncology (85)
Indications (155)
Infectious disease (3225)
Inflammatory bowel disease (208)
Inflation Reduction Act (15)
Influenza (126)
Intellectual property (270)
Interviews (466)
IPO (15918)
IRA (58)
Job creations (3924)
Job search strategy (1795)
JPM (70)
Kidney cancer (19)
Labor market (91)
Layoffs (648)
Leadership (45)
Legal (8282)
Liver cancer (105)
Longevity (27)
Lung cancer (738)
Lymphoma (411)
Machine learning (53)
Management (57)
Manufacturing (938)
MASH (188)
Medical device (14689)
Medtech (14768)
Mergers & acquisitions (18921)
Metabolic disorders (1549)
mRNA (206)
Multiple sclerosis (168)
NASH (24)
Neurodegenerative disease (413)
Neuropsychiatric disorders (114)
Neuroscience (3294)
Neurotech (2)
NextGen: Class of 2026 (6356)
Non-profit (4308)
Now hiring (58)
Obesity (766)
Opinion (317)
Ovarian cancer (180)
Pain (242)
Pancreatic cancer (257)
Parkinson's disease (350)
Partnered (32)
Patents (558)
Patient recruitment (615)
Peanut (59)
People (57587)
Pharmaceutical (45)
Pharmacy benefit managers (36)
Phase 1 (20867)
Phase 2 (29893)
Phase 3 (23227)
Pipeline (7130)
Policy (362)
Postmarket research (2818)
Preclinical (8557)
Press Release (56)
Prostate cancer (288)
Psychedelics (59)
Radiopharmaceuticals (306)
Rare diseases (1093)
Real estate (5761)
Recruiting (68)
Regulatory (26833)
Reports (45)
Research institute (2531)
Resumes & cover letters (426)
Rett syndrome (33)
RNA editing (19)
RSV (90)
Schizophrenia (176)
Series A (269)
Series B (200)
Service/supplier (11)
Sickle cell disease (110)
Special edition (27)
Spinal muscular atrophy (170)
Sponsored (50)
Startups (3568)
State (1)
Stomach cancer (21)
Supply chain (122)
Tariffs (102)
The Weekly (118)
Vaccines (1190)
Venture capital (110)
Weight loss (526)
Women's health (104)
Worklife (23)
Date
Today (53)
Last 7 days (636)
Last 30 days (2689)
Last 365 days (30423)
2026 (8101)
2025 (30706)
2024 (34975)
2023 (39353)
2022 (50538)
2021 (54826)
2020 (53094)
2019 (45209)
2018 (34290)
2017 (32661)
2016 (31651)
2015 (35718)
2014 (28727)
2013 (23984)
2012 (25984)
2011 (26532)
2010 (25011)
Location
Africa (836)
Alabama (93)
Alaska (6)
Arizona (311)
Arkansas (14)
Asia (42142)
Australia (6978)
California (12003)
Canada (3206)
China (1281)
Colorado (501)
Connecticut (545)
Delaware (358)
Europe (96411)
Florida (1837)
Georgia (396)
Hawaii (4)
Idaho (59)
Illinois (982)
India (78)
Indiana (522)
Iowa (23)
Japan (495)
Kansas (123)
Kentucky (45)
Louisiana (37)
Maine (78)
Maryland (1475)
Massachusetts (8726)
Michigan (328)
Minnesota (657)
Mississippi (7)
Missouri (144)
Montana (28)
Nebraska (27)
Nevada (135)
New Hampshire (85)
New Jersey (3298)
New Mexico (21)
New York (3167)
North Carolina (1570)
North Dakota (9)
Northern California (5959)
Ohio (356)
Oklahoma (22)
Oregon (42)
Pennsylvania (2385)
Puerto Rico (21)
Rhode Island (51)
South America (1224)
South Carolina (75)
South Dakota (1)
Southern California (4733)
Tennessee (196)
Texas (1900)
United States (42861)
Utah (338)
Vermont (1)
Virginia (298)
Washington D.C. (82)
Washington State (965)
West Virginia (4)
Wisconsin (129)
Wyoming (2)
693,345 Results for "medical microinstruments s r l".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Anaergia S.r.l. Expands Scope at Three Biomethane Facilities Being Built for QGM S.á.r.l. in Italy, Increasing Contracts by C$17 Million
March 17, 2026
·
3 min read
Press Releases
Disclosure of a transparency notification from AOC Pharma S.à r.l.
March 1, 2026
·
2 min read
Press Releases
Stallergenes Greer Expands Venom Immunotherapy Production Capacity With Acquisition of Entomon s.r.l.
January 7, 2026
·
5 min read
Press Releases
Digital Disruption in Life Sciences: L7 Informatics Says Competitive Advantage Will Come From Governed Execution
L7 Informatics CEO explains why the next wave of life sciences innovation depends on digital unified platforms that orchestrate workflows, contextualize data, and enable AI-actionable operations.
February 12, 2026
·
1 min read
Press Releases
Spectral Medical Provides Update on PMA Submission Timing for PMX-20R
February 26, 2026
·
3 min read
Opinion
Rare Disease Patients Can’t Wait for Regulatory Process
The U.S. Senate has a plan to improve drug development for rare disease patients. The exit of controversial CBER chief Vinay Prasad will help clear the path.
March 11, 2026
·
5 min read
·
Joshua R. Mansbach
Press Releases
Ficerafusp Alfa 2000mg Q2W Demonstrates Deep, Durable Responses in 1L R/M HPV-Negative HNSCC and Supports Development of Less Frequent Dosing Regimen
February 19, 2026
·
9 min read
Funding
R1 Leads Busy Fundraising Day With $77.5M Series A Raise for Kidney Disease
Alongside R1 Therapeutics, Mestag Therapeutics and iDEL Therapeutics also brought in money on Tuesday, helping to push their respective cancer portfolios forward.
March 18, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Bicara Therapeutics Announces Ficerafusp Alfa Granted Breakthrough Therapy Designation by U.S. FDA for 1L HPV-Negative R/M HNSCC
October 14, 2025
·
7 min read
Press Releases
Flare Therapeutics Appoints Stephen L. Eck, M.D., Ph.D., as Chief Medical Officer
January 9, 2026
·
4 min read
1 of 69,335
Next
